ServareGMP is a new non-profit biotechnology organization formed by long time experts in the field, deeply skilled across industry, with a track record of success across a wide range of programs from discovery through commercialization.
ServareGMP’s mission is to increase deployment of very low-cost biologics medicines including monoclonal antibodies, bi-specific antibodies, fusion proteins, other recombinant proteins, vectors, cell and gene therapies, mRNA-based therapeutics, and vaccine API.
ServareGMP was established to serve populations at risk from:
- Current and Future Outbreaks
- Challenging Bacterial and Fungal Infections
- Parasite-caused Diseases
- Other Unmet Needs of the Displaced and the Vulnerable.
Servare is utilizing cutting edge techniques to drive down the costs of needed medicines so that they are affordable to all.
Introduction
We work in partnership with for-profit organizations, universities, and institutes in flexible ways to bring forward breakthrough technology.
Our founders all have multiple decades of experience in engineering, developing, manufacturing, commercializing and launching biologic medicines resulting in multiple hundreds of program successes.
Our team's track record includes hundreds of programs accomplished. Our two biomanufacturing leaders have +60 biologics developed, manufactured and used in human patients.
We use our expertise in bioprocessing, including high-productivity cell-lines, concentrated fed-batch production, continuous perfusion, continuous purification, GMP manufacturing, and through our nonprofit structure, to do work for the public benefit.